201 related articles for article (PubMed ID: 35780261)
1. Cushing's disease: role of preoperative and primary medical therapy.
Castinetti F
Pituitary; 2022 Oct; 25(5):737-739. PubMed ID: 35780261
[TBL] [Abstract][Full Text] [Related]
2. Cushing's disease: adrenal steroidogenesis inhibitors.
Pivonello R; Simeoli C; Di Paola N; Colao A
Pituitary; 2022 Oct; 25(5):726-732. PubMed ID: 36036308
[TBL] [Abstract][Full Text] [Related]
3. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
[TBL] [Abstract][Full Text] [Related]
4. Medical management of Cushing's disease: When and how?
Castinetti F
J Neuroendocrinol; 2022 Aug; 34(8):e13120. PubMed ID: 35348261
[TBL] [Abstract][Full Text] [Related]
5. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
Varlamov EV; Han AJ; Fleseriu M
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of ketoconazole as a treatment for Cushing's disease in a retrospective cohort.
Viecceli C; Mattos ACV; Costa MCB; de Melo RB; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2022; 13():1017331. PubMed ID: 36277689
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Cushing's syndrome after adrenal autotransplantation.
Yesil S; Demir T; Akinci B; Ozdogan O; Gazioglu N; Hatemi H
Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):470-2. PubMed ID: 19885999
[TBL] [Abstract][Full Text] [Related]
8. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
9. Ketoconazole as second-line treatment for Cushing's disease after transsphenoidal surgery: systematic review and meta-analysis.
Viecceli C; Mattos ACV; Hirakata VN; Garcia SP; Rodrigues TDC; Czepielewski MA
Front Endocrinol (Lausanne); 2023; 14():1145775. PubMed ID: 37223017
[TBL] [Abstract][Full Text] [Related]
10. What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
Braun LT; Reincke M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101376. PubMed ID: 32063487
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
Perosevic M; Tritos NA
Drug Des Devel Ther; 2023; 17():1303-1312. PubMed ID: 37143705
[TBL] [Abstract][Full Text] [Related]
12. How best to monitor the specific side effects of medical treatments of Cushing's disease.
Castinetti F
Best Pract Res Clin Endocrinol Metab; 2022 Dec; 36(6):101718. PubMed ID: 36435719
[TBL] [Abstract][Full Text] [Related]
13. Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.
Fleseriu M; Castinetti F
Pituitary; 2016 Dec; 19(6):643-653. PubMed ID: 27600150
[TBL] [Abstract][Full Text] [Related]
14. Osilodrostat for the treatment of Cushing's disease.
Rasool S; Skinner BW
Expert Opin Pharmacother; 2021 Jun; 22(9):1099-1106. PubMed ID: 33703978
[TBL] [Abstract][Full Text] [Related]
15. Fluconazole for Hypercortisolism in Cushing's Disease: A Case Report and Literature Review.
Zhao Y; Liang W; Cai F; Wu Q; Wang Y
Front Endocrinol (Lausanne); 2020; 11():608886. PubMed ID: 33391186
[TBL] [Abstract][Full Text] [Related]
16. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
Engelhardt D; Weber MM
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
[TBL] [Abstract][Full Text] [Related]
17. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
18. Preoperative management of Cushing's syndrome with metyrapone for severe psychiatric disturbances.
Obinata D; Yamaguchi K; Hirano D; Yoshida T; Soma M; Takahashi S
Int J Urol; 2008 Apr; 15(4):361-2. PubMed ID: 18380829
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of Cushing's Disease.
Cuevas-Ramos D; Fleseriu M
Minerva Endocrinol; 2016 Sep; 41(3):324-40. PubMed ID: 26977887
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic options after surgical failure in Cushing's disease: A critical review.
Rubinstein G; Osswald A; Zopp S; Ritzel K; Theodoropoulou M; Beuschlein F; Reincke M
Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101270. PubMed ID: 31036383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
